GLENMARK PHARMACEUTICALS
Back to Balance Sheet
|
GLENMARK PHARMACEUTICALS Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Capital Work in Progress | ₹542 Cr | ₹419 Cr | ₹1,066 Cr | ₹921 Cr | ₹1,218 Cr |
What is the latest Capital Work in Progress ratio of GLENMARK PHARMACEUTICALS ?
| Year | Capital Work in Progress |
|---|---|
| Mar2025 | ₹542 Cr |
| Mar2024 | ₹419 Cr |
| Mar2023 | ₹1,066 Cr |
| Mar2022 | ₹921 Cr |
| Mar2021 | ₹1,218 Cr |
How is Capital Work in Progress of GLENMARK PHARMACEUTICALS Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2025 | ₹542 Cr | 29.25 | |
| Mar2024 | ₹419 Cr | -60.66 | |
| Mar2023 | ₹1,066 Cr | 15.71 | |
| Mar2022 | ₹921 Cr | -24.36 | |
| Mar2021 | ₹1,218 Cr | - | |
Compare Capital Work in Progress of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹54,841.3 Cr | -3.4% | -2.4% | 32.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹386,905.0 Cr | -5.2% | -7.6% | -8.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,357.0 Cr | -5.6% | -7.3% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,788.0 Cr | -0.6% | 4.8% | 25% | Stock Analytics | |
| CIPLA | ₹110,628.0 Cr | -4.5% | -9.7% | -4.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,441.5 Cr | -2.6% | -9.7% | -10.5% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | -3.4% |
-2.4% |
32.4% |
| SENSEX | -2.1% |
-3% |
6.8% |
You may also like the below Video Courses